WALKER & DUNLOP INC's ticker is WD and the CUSIP is 93148P102. A total of 168 filers reported holding WALKER & DUNLOP INC in Q4 2015. The put-call ratio across all filers is 11.93 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $320,000 | +2.6% | 3,323 | +38.0% | 0.00% | +50.0% |
| Q1 2022 | $312,000 | -1.9% | 2,408 | +14.3% | 0.00% | 0.0% |
| Q4 2021 | $318,000 | -2.8% | 2,106 | -32.7% | 0.00% | 0.0% |
| Q2 2021 | $327,000 | +13.1% | 3,130 | +11.4% | 0.00% | 0.0% |
| Q1 2021 | $289,000 | -43.8% | 2,809 | -49.7% | 0.00% | -33.3% |
| Q4 2020 | $514,000 | +136.9% | 5,582 | +30.5% | 0.00% | +50.0% |
| Q2 2020 | $217,000 | -16.5% | 4,278 | +6.4% | 0.00% | 0.0% |
| Q4 2019 | $260,000 | -71.4% | 4,020 | -76.6% | 0.00% | -66.7% |
| Q3 2018 | $909,000 | +17.1% | 17,181 | +23.2% | 0.01% | +20.0% |
| Q2 2018 | $776,000 | -80.4% | 13,945 | -79.0% | 0.01% | -50.0% |
| Q1 2018 | $3,952,000 | +26.1% | 66,486 | +0.8% | 0.01% | +42.9% |
| Q4 2017 | $3,135,000 | +33.7% | 65,991 | +47.4% | 0.01% | +16.7% |
| Q3 2017 | $2,344,000 | +17.4% | 44,776 | +9.4% | 0.01% | +20.0% |
| Q2 2017 | $1,997,000 | +10.0% | 40,912 | -6.1% | 0.01% | 0.0% |
| Q1 2017 | $1,816,000 | +18.5% | 43,566 | -11.3% | 0.01% | +25.0% |
| Q4 2016 | $1,533,000 | -21.4% | 49,122 | -36.4% | 0.00% | -33.3% |
| Q3 2016 | $1,950,000 | -2.3% | 77,193 | -11.9% | 0.01% | 0.0% |
| Q2 2016 | $1,996,000 | -10.7% | 87,660 | -4.8% | 0.01% | -14.3% |
| Q1 2016 | $2,235,000 | -31.3% | 92,094 | -18.5% | 0.01% | -22.2% |
| Q4 2015 | $3,254,000 | – | 112,936 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FIRST SABREPOINT CAPITAL MANAGEMENT LP | 380,000 | $36,610,000 | 7.15% |
| M.D. Sass, LLC | 327,036 | $31,506,000 | 5.95% |
| Conversant Capital LLC | 232,000 | $22,351,000 | 5.10% |
| Harspring Capital Management, LLC | 202,250 | $19,485,000 | 4.37% |
| PRECEPT MANAGEMENT LLC | 19,500 | $1,879,000 | 4.21% |
| GPM Growth Investors, Inc. | 59,907 | $5,771,000 | 3.76% |
| Phase 2 Partners, LLC | 66,447 | $6,402,000 | 3.29% |
| PRECEPT MANAGEMENT LLC | 15,000 | $1,445,000 | 3.24% |
| Kathmere Capital Management, LLC | 123,538 | $11,902,000 | 2.20% |
| MOODY ALDRICH PARTNERS LLC | 90,501 | $8,719,000 | 1.71% |